Ingredient or product comparison
The Mechanism Divide: Receptor-Specific vs Growth Factor Cascade
Peptide-based interventions target identified receptors in follicle biology. Copper peptides bind transforming growth factor-beta receptor II (TGF-βRII), modulating collagen remodeling and angiogenesis pathways around the follicle bulb. Research published in t
This source-based comparison does not add ratings or recommend a winner.
- Peptide-based interventions target identified receptors in follicle biology. Copper peptides bind transforming growth factor-beta receptor II (TGF-βRII), modulating collagen remodeling and angiogenesis pathways around the follicle bulb. Research published in the Journal of Cosmetic Dermatology found GHK-Cu increased follicle size by 22% and hair density by 18% over 24 weeks in miniaturized follicles, operating through direct VEGF upregulation and extracellular matrix protein synthesis. The peptide doesn't stimulate the follicle indirectly. It binds a receptor, triggers second messenger cascades (cAMP, ERK1/2 phosphorylation), and changes gene expression within 6–12 hours.
- PRP operates through a fundamentally different route. Centrifugation separates platelets from erythrocytes and leukocytes; when those platelets are activated (calcium chloride, thrombin, or mechanical disruption), they degranulate and release alpha-granule contents. Primarily platelet-derived growth factor (PDGF-AB, PDGF-BB), transforming growth factor-beta (TGF-β1, TGF-β2), insulin-like growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF). Each of these binds different receptor families on follicle stem cells, dermal papilla cells, and perifollicular endothelial cells. The result is paracrine stimulation. Broad, multi-pathway activation rather than targeted receptor engagement. Studies in Dermatologic Surgery reported mean hair density increases of 19–31% at 6 months post-treatment in androgenetic alopecia subjects, but outcomes vary significantly based on platelet concentration (baseline 150,000–450,000 platelets/μL) and activation pro